Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Non-Current Liabilities (2024 - 2025)

Historic Total Non-Current Liabilities for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $403.9 million.

  • Kura Oncology's Total Non-Current Liabilities rose 65353.67% to $403.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $403.9 million, marking a year-over-year increase of 65353.67%. This contributed to the annual value of $344.7 million for FY2024, which is N/A changed from last year.
  • Kura Oncology's Total Non-Current Liabilities amounted to $403.9 million in Q3 2025, which was up 65353.67% from $374.3 million recorded in Q2 2025.
  • Kura Oncology's 5-year Total Non-Current Liabilities high stood at $403.9 million for Q3 2025, and its period low was $47.9 million during Q2 2024.